In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK ... on stocks such as Oxford BioMedica, Zealand Pharma, and Galapagos.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback